SOST and sclerosteosis: Although the original mutation C142R found in a Turkish patient suffering from Sclerosteosis possibly acts through a gene-dosage effect resulting from a diminished secretion of the variant protein [42], we were interested whether this mutation might also have a direct functional impact on LRP binding and Sclerostin's Wnt inhibition capabilities.